The Adrenal Gland: Central Relay in Health and Disease
暂无分享,去创建一个
[1] N. Reisch. Review of Health Problems in Adult Patients with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency , 2019, Experimental and Clinical Endocrinology & Diabetes.
[2] B. Boehm,et al. An Update on Addison’s Disease , 2018, Experimental and Clinical Endocrinology & Diabetes.
[3] M. Fassnacht,et al. Advanced Adrenocortical Carcinoma – What to do when First-Line Therapy Fails? , 2018, Experimental and Clinical Endocrinology & Diabetes.
[4] E. Baudin,et al. Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry. , 2018, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[5] G. Di Dalmazi. Adrenal Incidentaloma : Picking out the High-Risk Patients , 2019 .
[6] A. Grossman,et al. Metastatic Phaeochromocytoma: Spinning Towards More Promising Treatment Options , 2018, Experimental and Clinical Endocrinology & Diabetes.
[7] M. Reincke,et al. Inherited Forms of Primary Hyperaldosteronism: New Genes, New Phenotypes and Proposition of A New Classification , 2018, Experimental and Clinical Endocrinology & Diabetes.
[8] M. Bidlingmaier,et al. Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism , 2018, Experimental and Clinical Endocrinology & Diabetes.
[9] M. Reincke,et al. Treatment of Unilateral PA by Adrenalectomy: Potential Reasons for Incomplete Biochemical Cure , 2018, Experimental and Clinical Endocrinology & Diabetes.
[10] C. Dimopoulou,et al. “The Adrenal Gland: Central Relay in Health and Disease - Current Challenges and Perspectives 2018” – Cushing’s Disease , 2018, Experimental and Clinical Endocrinology & Diabetes.
[11] F. Beuschlein,et al. Perioperative Management of Endocrine Active Adrenal Tumors , 2018, Experimental and Clinical Endocrinology & Diabetes.
[12] F. Beuschlein,et al. Metabolic Alterations in Patients with Pheochromocytoma , 2018, Experimental and Clinical Endocrinology & Diabetes.
[13] M. Theodoropoulou,et al. Genetics of Cushing's disease , 2018, Clinical endocrinology.
[14] K. Pacak,et al. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification , 2017, Endocrine reviews.
[15] W. Young,et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. , 2017, The lancet. Diabetes & endocrinology.
[16] M. Reincke,et al. Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism , 2017, Hypertension.
[17] A. Tabarin,et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. , 2016, European journal of endocrinology.
[18] P. Chanson,et al. Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. , 2015, European journal of endocrinology.
[19] J. Thigpen. Combination Chemotherapy in Advanced Adrenocortical Carcinoma , 2012 .
[20] F. Veglio,et al. Prevalence and Characteristics of Familial Hyperaldosteronism: The PATOGEN Study (Primary Aldosteronism in TOrino-GENetic forms) , 2011, Hypertension.
[21] J. Bertherat,et al. Cushing's disease. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[22] M. Srivastava. Carney complex. , 2004, Dermatology online journal.
[23] N. Shimizu. [Cushing's disease]. , 1993, Nihon rinsho. Japanese journal of clinical medicine.